About
EndyMed Medical, founded in 2007, is a medical device company focused on energy-based aesthetic treatment systems for both professional and consumer markets. The company’s core technology is its proprietary 3DEEP radiofrequency (RF) technology, which offers effective solutions for skin rejuvenation, wrinkle reduction, fractional skin resurfacing, microneedling, collagen remodeling, and body contouring. EndyMed's product range includes devices that utilize 3DEEP RF technology and LED light therapies to address various skin conditions, such as skin tightening, acne scarring, and wrinkle treatment. Their systems are designed for use in medical aesthetic clinics, providing non-invasive and minimally invasive solutions for skin and body enhancement. The company emphasizes precision and safety, ensuring controlled RF energy delivery to stimulate collagen and elastin production without damaging the skin surface. In 2025, EndyMed merged with Shanghai Haohai Biological Technology Co., Ltd., enhancing its global market position and operational efficiency. The company is led by CEO Yossi Bar-On, VP of International Sales & Marketing Amir Meir Ganun, and CFO Rami Aviram. EndyMed is committed to supporting its clients with comprehensive marketing, clinical support, and customer service programs.
Technologies
Keywords
Company Information
-
Employees 46
-
Founded 2007
-
Annual Revenue $22779000
-
Total Funding $7000000
Location
Freehold Township, New Jersey, United States
